Articles related to HEART ATTACK/MYOCARDIAL INFARCTION

A recent study involving 4,400 participants revealed that two major statins—rosuvastatin and atorvastatin—are equally effective at reducing heart attacks, strokes, and all-cause deaths. However, it was found that the rosuvastatin group was more likely (7.2%) to develop type 2 diabetes than the atorvastatin group (5.3%).

The recent multicenter trial on ECLS in cardiogenic shock complicating acute myocardial infarction raises questions about its efficacy and safety.

The study provides compelling evidence that complete revascularization in older patients with myocardial infarction and multivessel disease may offer a more favorable risk profile. Consider revisiting your treatment strategies in light of these findings.

In this video, Zack Shinar, MD, discusses the future of cardiac arrest and the role of extracorporeal membrane oxygenation (ECMO) in the emergency department (ED). Dr. Shinar is a leading expert in ECMO and has been instrumental in developing new protocols for its use in the ED. Dr. Shinar begins by discussing the current state of CPR. He notes that CPR is only effective in about 10% of cases, and that even when it is successful, patients often suffer significant brain damage. He then discusses ECMO, which is a life-support machine that can oxygenate the blood outside of the body. ECMO has been shown to be effective in saving the lives of patients with cardiac arrest, and Dr. Shinar believes that it should be used more widely in the ED. Dr. Shinar then discusses the challenges of using ECMO in the ED. He notes that ECMO is a complex procedure that requires specialized training and equipment. He also notes that ECMO can be expensive, and that it is not always available in all hospitals.

Risks for ischemic stroke, hemorrhagic stroke, MI, and pulmonary embolism were all lower for older patients receiving a bivalent vaccine booster versus the monovalent vaccine. The results “provide reassurance regarding the continued use of this bivalent vaccine.”

Danish researchers assembled a prospective observational cohort study of 9,533 asymptomatic people aged 40 years or older with no known ischemic heart disease to define characteristics of subclinical coronary atherosclerosis associated with the development of myocardial infarction. The study’s findings are startling.